Recent Updates

Modified on: 
May 13, 2019

This first chapter of the Clinical Guide to Transfusion provides an overview of the blood system in Canada, the regulations and standards that are in place and the organizations and professionals that, together, ensure transfusion medicine safety for Canadian patients. 

Transfusion
Modified on: 
May 13, 2019

Author: Mindy Goldman, MD, FRCPC
Online publication date: March 2012, updated July 2018

Transfusion
Modified on: 
Apr 2, 2019

Modified or specialty blood components may be useful in specific clinical settings to reduce the risk of transfusion-related harm. Specialty blood products available to physicians include CMV-seronegative, irradiated, and washed red blood cells or platelets. This chapter describes the preparation of these blood components and the clinical setting in which they are of greatest benefit.

Transfusion
Modified on: 
Feb 26, 2019

Transfusion-related acute lung injury (TRALI) is a rare but serious syndrome characterized by sudden acute respiratory distress following transfusion. It is defined as new, acute lung injury (ALI) during or within six hours after blood product administration in the absence of temporally-associated risk factors for ALI. All plasma-containing blood products have been implicated in TRALI, including rare reports with IVIg and cryoprecipitate.

Transfusion
Modified on: 
Feb 26, 2019

Blog Landing Page

Organs and Tissues
Modified on: 
Feb 21, 2019

Read more posts from the Research, Education and Discovery blog at blood.ca/RED

Transfusion
Organs and Tissues
Stem Cells
Modified on: 
Feb 21, 2019

Read more posts from the Research, Education and Discovery blog at blood.ca/RED

Transfusion
Organs and Tissues
Stem Cells
Modified on: 
Feb 21, 2019

Read more posts from the Research, Education and Discovery blog at blood.ca/RED

Transfusion
Organs and Tissues
Stem Cells
Modified on: 
Feb 12, 2019

Authors: Robert Skeate, MD, MSc and Mindy Goldman, MD, FRCPC
Online publication date: July 2014

Key points

Transfusion
Modified on: 
Feb 12, 2019

Molecular immunohematology refers to the detection of the molecular genetic basis of an antigen, rather than the antigen alone.  Use of molecular testing in clinical laboratories requires knowledge of the molecular basis of blood group antigens and the availability of suitable genotyping methods that can be used in our testing environment.

Transfusion

Pages